PHASE 2 STUDY OF THE SAFETY AND TOLERABILITY OF MARAVIROC-CONTAINING REGIMENS TO PREVENT HIV INFECTION IN MEN WHO HAVE SEX WITH MEN (MSM) (HPTN 069/ACTG A5305)Roy M. Gulick, Kenneth H. Mayer, Mark A. Marzinke et al.|The Journal of Infectious Diseases|2016Cited by 47
Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in WomenRoy M. Gulick, Kenneth H. Mayer, Timothy Wilkin et al.|Annals of Internal Medicine|2017Cited by 31
Phase 2 Study of the Safety and Tolerability of Maraviroc-Containing Regimens to Prevent HIV Infection in Men Who Have Sex With Men (HPTN 069/ACTG A5305)Ian McGowan, Marybeth McCauley, Ian Frank et al.|eScholarship (California Digital Library)|2020Cited by 28
Sexual behavior and medication adherence in men who have sex with men participating in a pre-exposure prophylaxis study of combinations of Maraviroc, Tenofovir Disoproxil Fumarate and/or Emtricitabine (HPTN 069/ACTG 5305)Kenneth H. Mayer, Krista Yuhas, K. Rivet Amico et al.|AIDS and Behavior|2022Cited by 4